.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for addition of patients along with MASLD and size of liver results in cardio-- kidney-- metabolic tests, when data advise mechanistically probable perks as well as clinical security-- and summarizes factors for trial style and regulatory approval.